Plus Gum Creates Fast-Acting and Tasty Medical Cannabis Edibles

Visit the Plus Products Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors.

Plus Gum Team

In Episode 15 of Brandon David’s Investing in Cannabis, he interviews two of the executives at Plus Gum, which is based in the San Francisco area. CEO Jake Heimark and Founder Justin “Crunchy” Crunchington, who serves as Head of R&D, discuss their backgrounds and the history of their product, the challenges to getting it properly formulated and the details of their patent-pending product, which is fast-acting, tastes great and low-calorie.  Plus Gum is tested by both Steep Hill and CW Analytical.  The company raised $300K from “friends and family” in June and will be looking to raise additional capital in mid-2016 as it ramps up sales, achieves product consistency and better understands its audience. Their gum, which has six pieces with 25mg of THC and 5mg of CBD each, sells for $25 retail.

Plus Gum Cannabis Package

For fact-based information on Plus Products, view the company’s sponsored Investor Dashboard.

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter